Literature DB >> 7509363

Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitis.

R González-Amaro1, C García-Monzón, L García-Buey, R Moreno-Otero, J L Alonso, E Yagüe, J P Pivel, M López-Cabrera, E Fernández-Ruiz, F Sánchez-Madrid.   

Abstract

Tumor necrosis factor alpha (TNF-alpha) is a multifunctional cytokine that has an important role in the pathogenesis of inflammation, cachexia, and septic shock. Although TNF-alpha is mainly produced by macrophages, there is evidence regarding TNF-alpha production by cells that are not derived from bone marrow. TNF-alpha production by normal and inflamed human liver was assessed at both mRNA and protein levels. Using a wide panel of novel anti-TNF-alpha monoclonal antibodies and a specific polyclonal antiserum, TNF-alpha immunoreactivity was found in hepatocytes from patients chronically infected with either hepatitis B virus (HBV) or hepatitis C virus. Minimal TNF-alpha immunoreactivity was detected in the mononuclear cell infiltrate and Kupffer cells. In situ hybridization experiments using a TNF-alpha RNA probe showed a significant expression of TNF-alpha mRNA in hepatocytes, Kupffer cells, and some infiltrating mononuclear cells. By contrast, TNF-alpha was detected at low levels in liver biopsies from normal individuals or patients with alcoholic liver disease and low expression of TNF-alpha mRNA was observed in these specimens. Transfection of HepG2 hepatoblastoma cells with either HBV genome or HBV X gene resulted in induction of TNF-alpha expression. Our results demonstrate that viral infection induces, both in vivo and in vitro, TNF-alpha production in hepatocytes, and indicate that the HBV X protein may regulate the expression of this cytokine. These findings suggest that TNF-alpha may have an important role in human liver diseases induced by viruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7509363      PMCID: PMC2191405          DOI: 10.1084/jem.179.3.841

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  Tumor necrosis factor-alpha production induced in T lymphocytes through the AIM/CD69 activation pathway.

Authors:  A G Santis; M R Campanero; J L Alonso; A Tugores; M A Alonso; E Yagüe; J P Pivel; F Sánchez-Madrid
Journal:  Eur J Immunol       Date:  1992-05       Impact factor: 5.532

2.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

3.  A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF.

Authors:  M Kriegler; C Perez; K DeFay; I Albert; S D Lu
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

4.  Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA.

Authors:  M A Sells; M L Chen; G Acs
Journal:  Proc Natl Acad Sci U S A       Date:  1987-02       Impact factor: 11.205

5.  Genes for IFN-beta-2 (IL-6), tumor necrosis factor, and IL-1 are expressed at high levels in the organs of normal individuals.

Authors:  M G Tovey; J Content; I Gresser; J Gugenheim; B Blanchard; J Guymarho; P Poupart; M Gigou; A Shaw; W Fiers
Journal:  J Immunol       Date:  1988-11-01       Impact factor: 5.422

6.  Induction of tumor necrosis factor expression and resistance in a human breast tumor cell line.

Authors:  D Spriggs; K Imamura; C Rodriguez; J Horiguchi; D W Kufe
Journal:  Proc Natl Acad Sci U S A       Date:  1987-09       Impact factor: 11.205

7.  Cellular and humoral immune reactions in chronic active liver disease. I. Lymphocyte subsets in liver biopsies of patients with untreated idiopathic autoimmune hepatitis, chronic active hepatitis B and primary biliary cirrhosis.

Authors:  H F Eggink; H J Houthoff; S Huitema; C H Gips; S Poppema
Journal:  Clin Exp Immunol       Date:  1982-10       Impact factor: 4.330

8.  Molecular cloning and expression of human tumor necrosis factor and comparison with mouse tumor necrosis factor.

Authors:  A Marmenout; L Fransen; J Tavernier; J Van der Heyden; R Tizard; E Kawashima; A Shaw; M J Johnson; D Semon; R Müller
Journal:  Eur J Biochem       Date:  1985-11-04

9.  Different functional sites on rIFN-alpha 2 and their relation to the cellular receptor binding site.

Authors:  M Cebrián; E Yagüe; M O de Landázuri; M Rodíguez-Moya; M Fresno; N Pezzi; S Llamazares; F Sánchez-Madrid
Journal:  J Immunol       Date:  1987-01-15       Impact factor: 5.422

10.  Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor.

Authors:  B Y Rubin; S L Anderson; S A Sullivan; B D Williamson; E A Carswell; L J Old
Journal:  J Exp Med       Date:  1986-10-01       Impact factor: 14.307

View more
  64 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Effect of hepatocyte apoptosis induced by TNF-alpha on acute severe hepatitis in mouse models.

Authors:  Guo-Qing Zang; Xia-Qiu Zhou; Hong Yu; Qing Xie; Guo-Ming Zhao; Bin Wang; Qing Guo; Yue-Qin Xiang; Dan Liao
Journal:  World J Gastroenterol       Date:  2000-10       Impact factor: 5.742

3.  Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.

Authors:  Ko-Ming Lin; Tien-Tsai Cheng; Jing-Chi Lin; Chung-Jen Chen
Journal:  Clin Rheumatol       Date:  2015-05-05       Impact factor: 2.980

4.  Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis.

Authors:  N Zhu; A Khoshnan; R Schneider; M Matsumoto; G Dennert; C Ware; M M Lai
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Interleukin 1 beta and phorbol ester induce tumour necrosis factor alpha production in a hepatic cell line (HepG2).

Authors:  S Frede; J Fandrey; W Jelkmann
Journal:  Pflugers Arch       Date:  1996-04       Impact factor: 3.657

6.  Single-dose infliximab in hepatitis C genotype 1 treatment-naive patients with high serum tumour necrosis factor-alpha does not influence the efficacy of pegylated interferon alpha-2b/ribavirin therapy.

Authors:  Curtis Cooper; Stephan Shafran; Susan Greenbloom; Robert Enns; John Farley; Nir Hilzenrat; Kurt Williams; Magdy Elkashab; Nabil Abadir; Manuela Neuman
Journal:  Can J Gastroenterol Hepatol       Date:  2013-11-08

7.  HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release.

Authors:  M J Koziel; D Dudley; N Afdhal; A Grakoui; C M Rice; Q L Choo; M Houghton; B D Walker
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

8.  Association between polymorphism of tumor necrosis factor-alpha promoter and response to lamivudine treatment in patients with chronic hepatitis B.

Authors:  Yong Kwang Park; Jung Min Lee; Do Young Kim; Hye Young Chang; Ja Kyung Kim; Chun Kyon Lee; Jun Yong Park; Sang Hoon Ahn; Kwan Sik Lee; Kwang Hyub Han
Journal:  Dig Dis Sci       Date:  2009-10-15       Impact factor: 3.199

Review 9.  New insights into tumor-host interactions in lymphoma metastasis.

Authors:  V Umansky; V Schirrmacher; M Rocha
Journal:  J Mol Med (Berl)       Date:  1996-07       Impact factor: 4.599

10.  Deadly liaisons: fatal attraction between CCN matricellular proteins and the tumor necrosis factor family of cytokines.

Authors:  Chih-Chiun Chen; Lester F Lau
Journal:  J Cell Commun Signal       Date:  2009-11-07       Impact factor: 5.782

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.